Dementia and Heritability

Dementia includes a group of conditions that affect memory, thinking, and behaviour. The most common types are Alzheimer’s disease (60–70% of cases), vascular dementia (10–20%), Lewy body dementia (10–15%), and frontotemporal dementia (5–10%), according to the Alzheimer’s Association (2025). Mixed dementia, which blends features of these types, is also quite common. Many people with dementia have relatives with the condition, raising questions about whether it runs in families due to genetics.

Heritability means how much of a condition is passed down through genes. For dementia, this varies - Alzheimer’s has a heritability of 60 - 80%, while vascular dementia is lower, as noted in a 2023 study by the National Institute on Aging.

Genes play a role with rare changes causing early dementia and common gene differences raising the risk for later cases. However, lifestyle choices, heart health, and surroundings also matter a lot, making dementia a mix of many influences.

Dementia Hub looks into how genes affect each dementia type, measures the family risk, and points out things people can change, like diet or exercise. It aims to clear up how much dementia might be inherited, helping families understand their risks. As the Alzheimer’s Society (2025) suggests, knowing both genetic and lifestyle factors is key to managing this condition.

Genetic Contributions to Alzheimer’s Disease

Alzheimer’s disease, the most common type of dementia, has a big genetic link, especially in cases that start early (before age 65), which make up 1 - 5% of all AD cases. Understanding these genetic factors helps explain why some people are more likely to develop it.

Early-Onset Alzheimer’s Disease (EOAD)
Early-onset AD runs strongly in families, with 90 - 100% of cases tied to changes in three key genes:

APP (Amyloid Precursor Protein): Found on chromosome 21, this gene change, discovered in 1991, boosts amyloid-beta (Aβ) build up, forming sticky plaques. It affects 10 - 15% of early cases.
PSEN1 (Presenilin 1): Located on chromosome 14, this mutation, found in 1995, messes with a brain process, increasing harmful Aβ42. It causes 50 - 70% of early-onset cases.
PSEN2 (Presenilin 2): On chromosome 1, this rarer change, also found in 1995, adds to 5% of cases.

These gene changes almost guarantee AD, often hitting between ages 30 - 50. A 2019 study in Nature Genetics found 10 - 15% of people with early AD have a close family member with dementia, and a simple genetic test can spot these changes. Families with Down syndrome, where an extra chromosome 21 boosts APP, often see AD by age 60.

Late-Onset Alzheimer’s Disease (LOAD)
Late-onset AD, starting after 65, is more common and less directly passed down but still has genetic roots. The APOE gene on chromosome 19 is a major player:

APOE ε4: One copy raises AD risk 3 - 4 times, and two copies jump it to 8 - 12 times, per a 1993 Proceedings of the National Academy of Sciences study. About 20 - 25% of people have one copy, and 2 - 3% have two.
APOE ε2: This rare version lowers risk by 40%.
APOE ε3: The most common type, it doesn’t affect risk much.

Heritability for late-onset AD is 60 - 80%, according to a 2020 Alzheimer’s & Dementia study, involving many genes. Since 2009, large gene studies have found over 30 risk spots, like TREM2, CLU, and BIN1, each adding a small risk (1.1 - 2.0 times). A 2023 Nature Genetics study created a risk score from these genes, predicting AD with 80% accuracy in high-risk groups.

Family history matters: having a close relative with AD doubles or triples your risk, per a 2017 Neurology study. Twin research shows 60 - 80% of identical twins share AD, compared to 20 - 40% of non-identical twins, showing genes play a big role alongside lifestyle and environment.

Genetic Contributions to Vascular Dementia

Vascular dementia happens when poor blood flow to the brain causes memory and thinking problems. It’s less tied to genes than Alzheimer’s, with about 30 - 50% of the risk coming from heredity, according to a 2018 Brain study. Genes mostly affect the blood vessel health that leads to this condition rather than the dementia itself.

Rare Genetic Forms
Some uncommon genetic conditions play a big role:

CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy): This rare disorder comes from changes in the NOTCH3 gene on chromosome 19. Found in 1996, it damages small blood vessels, leading to vascular dementia in 80% of people by age 60. It affects less than 1% of cases and is almost certain to happen if you have the gene.
Other Rare Conditions: Changes in genes like COL4A1 or HTRA1 can cause blood vessel problems that raise the risk of vascular dementia.

Common Genetic Influences
Everyday gene differences linked to heart and blood vessel issues can also increase the chance of vascular dementia:

MTHFR: Variations in this gene affect homocysteine levels, which can lead to strokes and contribute to dementia.
ACE and APOE: These gene changes can raise blood pressure and artery hardening, boosting risk by 20 - 30%, per a 2020 Hypertension study.

Having a family history of stroke or heart disease doubles the risk. However, lifestyle factors like high blood pressure, diabetes, and smoking are the biggest drivers, making up 60 - 70% of the risk, according to a 2020 Lancet Commission. Unlike Alzheimer’s, no single gene strongly predicts vascular dementia, and risk score tools are not as advanced.

Genetic Contributions to Lewy Body Dementia

Lewy body dementia (LBD) includes dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). It has a moderate chance of being passed down through genes, with about 40 - 60% of the risk linked to heredity, according to a 2019 Nature Reviews Neurology study.

Early-Onset LBD
In rare cases, LBD starts early (before age 65), affecting less than 5% of people. This is often due to changes in two genes tied to Parkinson’s:

SNCA (alpha-synuclein): Found in 1997, this gene change boosts the build up of Lewy bodies (protein clumps) and almost always leads to LBD.
LRRK2: Discovered in 2004, this mutation also increases Lewy body formation and is strongly linked to early LBD.

Late-Onset LBD
For LBD that starts later (after 65), several genes play a role:

GBA (Glucocerebrosidase): Changes in this gene, found in 2011, raise LBD risk 5 - 8 times, especially in PDD, by making it harder to clear alpha-synuclein.
APOE ε4: This gene variant, also linked to Alzheimer’s, increases DLB risk 2 - 3 times, per a 2018 Neurology study.
Other Genes: Studies have spotted small risk factors in genes like TMEM175 and SCARB2.

Having a family member with Parkinson’s or LBD doubles to quadruples your risk. However, only 10–15% of LBD patients have a close relative with dementia. Things like exposure to pesticides also matter a lot, according to a 2021 Environmental Health study.

Genetic Contributions to Frontotemporal Dementia

Frontotemporal dementia (FTD) affects the front and side parts of the brain, impacting behaviour and thinking. It has a strong family link in about 40 - 50% of cases, according to a 2020 Lancet Neurology study.

Family-Related FTD
When FTD runs in families, certain gene changes are often to blame:

MAPT (Tau): Found on chromosome 17 and discovered in 1998, this change causes problems with tau protein, affecting 10 - 20% of family cases.
C9orf72: Identified in 2011, this gene has a repeating pattern that’s the top cause, making up 25 - 40% of family cases and 5 - 10% of random cases.
GRN (Progranulin): Discovered in 2006, changes here lower progranulin levels and account for 5 - 20% of family cases.

These gene changes are passed down directly from parents, and 80 - 90% of people with them will develop FTD by age 70. About 30 - 50% of FTD patients have a close family member, like a parent or sibling, with dementia.

Random FTD
For FTD that doesn’t run in families, the genetic link is weaker (20 - 30%). Studies have found small risk spots, like TMEM106B, which can raise the chance of FTD by 1.5 - 2 times. Things like head injuries might also play a role, though we know less about these outside factors.

Quantifying Hereditary Risk

The chance of inheriting dementia depends on the type and when it starts. Here’s a simple breakdown:

Alzheimer’s Disease: Early onset AD (before age 65) is almost always passed down if someone has certain gene changes, close to 100%. Late onset AD (after 65) has a 60 - 80% chance of being linked to genes, and having a family member with it doubles your risk, according to experts.
Vascular Dementia: This type has a 30 - 50% genetic link, mostly tied to genes affecting blood vessels. If a close relative had a stroke, your risk doubles.
Lewy Body Dementia: About 40 - 60% of LBD cases are influenced by genes. Having a family member with LBD or Parkinson’s can raise your risk 2 - 4 times.
Frontotemporal Dementia: In families where FTD runs, 40 - 50% is genetic, and 80 - 90% of people with these gene changes will get it by age 70. For cases that don’t run in families, the genetic link drops to 20 - 30%.

A 2023 study in Alzheimer’s Research & Therapy found that 15 - 20% of all dementia cases have a clear family connection, but only 1 - 2% come from gene changes that almost guarantee the disease. Scientists are working on tools called polygenic risk scores to predict risk better by looking at many genes together. However, these aren’t used in regular doctor visits yet because of worries about how to handle genetic test results and privacy.

Understanding these risks helps families plan, but lifestyle choices like eating well and staying active also play a big role in lowering the chances.

Non-Genetic Factors and Their Interaction with Genetics

Genes can raise the risk of dementia, but things we can control, like lifestyle and surroundings, play a huge part too. These non genetic factors often team up with genes to affect how likely someone is to get dementia. Understanding this mix helps people take steps to lower their chances.

Blood Vessel Health Risks
Problems like high blood pressure, diabetes, and smoking make dementia more likely, especially for people with the APOE ε4 gene. These issues can boost Alzheimer's risk by 20 - 30%. But keeping them in check, like with medicine or quitting smoking, can cut the risk by up to 40%. This shows how fixing heart health can protect the brain.

Daily Habits
What you eat and how active you are matters a lot. A healthy diet full of fruits, veggies, and fish (like the Mediterranean style) can lower dementia risk by 30 - 40%, even if you have risky genes. Getting 150 minutes of exercise each week, like walking or swimming, helps keep the brain sharp and fights off decline. Staying mentally active with puzzles or learning new skills also helps.

Learning and Brain Strength
People with more education build a stronger "brain reserve," which can delay dementia signs by 2 - 5 years. This means the brain can handle damage better before symptoms show up.

Surroundings and Exposures
Things in the environment, like pesticides or dirty air, can raise the risk of Lewy body dementia or Alzheimer's by 20%, hitting harder if you have certain genes. Living in cleaner areas or avoiding harmful chemicals can make a difference.

Head Injuries
Getting a serious brain injury from falls or sports can double or triple the risk of frontotemporal dementia or Alzheimer's, especially with APOE ε4. Wearing helmets and being careful can help prevent this.

How Genes and Life Mix
The key is how genes and life choices interact. For example, APOE ε4 carriers who manage high blood pressure well have a 50% lower Alzheimer's risk than those who don't. This proves that even with genetic risks, healthy habits can change outcomes and open doors for prevention.

By focusing on these factors, people can reduce dementia's impact, no matter their genes. Small changes add up to big protection.

Genetic Testing and Counselling

Genetic testing can check for rare gene changes linked to dementia, like in APP, PSEN1, or C9orf72 genes, which often run in families. These tests are very accurate, up to 95%, and are best for people who get dementia early (before 65) or have many relatives with it.

However, for dementia that starts later, testing isn't as helpful because it involves many genes, not just one or two. Doctors suggest testing only if there's a strong reason, and always with clear talks about what it means.

Counselling is key before and after testing. A positive result might mean you're likely to get dementia, which can cause worry or sadness. Even a negative result doesn't mean zero risk, since lifestyle and other factors play a role. The Alzheimer's Association's 2024 guidelines say testing should happen only with full agreement and support from experts, like genetic counsellors, to help handle the news.

Some companies offer home tests that check for APOE gene changes, a common risk for Alzheimer's. But these aren't always great at predicting if you will actually get dementia, and people might misunderstand the results. This can lead to confusion or fear.

There are big ethical issues too. Testing raises concerns about keeping info private, facing unfair treatment (like at work or with insurance), and emotional stress. About 30% of people who get tested feel anxious afterward. Overall, testing can provide answers for some families, but it's not for everyone.

Talking to a doctor first ensures it's done right and helps manage any worries.

Prevention and Treatment

Knowing how dementia can run in families helps guide ways to prevent it and find better treatments. Genes play a part, but many cases can be avoided or slowed with smart choices, giving hope even to those with higher genetic risks.

Prevention
A big chunk of dementia, about 40%, can be prevented by healthy habits and fixing heart-related issues. This works for people with or without family risks. For example, regular exercise like walking 30 minutes a day, eating lots of fruits, veggies, and fish (think Mediterranean diet), and quitting smoking can lower the chance of getting dementia. Managing high blood pressure, diabetes, and cholesterol is key too, as these hurt blood flow to the brain. Even if you have genes like APOE ε4 that raise Alzheimer's risk, these steps can cut your odds by a lot. Simple things like staying mentally active with puzzles or social chats build brain strength and delay symptoms.

Treatments
Right now, treatments focus on easing symptoms, but new drugs aim to tackle the root causes. Lecanemab, approved in 2023 for Alzheimer's, clears harmful amyloid build up and slows memory loss in early cases. It's being tested for mixed dementia, where multiple types overlap. Other promising options include cilostazol for vascular dementia, which boosts blood flow, and neflamapimod for Lewy body dementia, which fights brain swelling. These are in late-stage trials, showing good early results for slowing decline.

Personalised Medicine
The future looks bright with custom care based on your genes and tests. Tools like polygenic risk scores (which look at many genes) and blood markers help predict who's at risk. This lets doctors tailor plans, like extra monitoring or specific drugs. Trials like VANTAGE in 2024 are checking combined treatments to handle mixed causes better. Overall, blending gene knowledge with lifestyle changes and new meds can improve lives and reduce dementia's impact.

Society, Research and Conclusions

Dementia often runs in families, sparking a lot of research into its causes. In recent years, world leaders have stepped up efforts. For example, the G7 has long pushed for more funding in dementia research, aiming to find better treatments by 2025.

Groups are calling for billions more in investments for studies on genes and early warning signs in the body. Raising awareness about gene risks can help people understand their chances.

When combined with education on things we can change like diet, exercise, and quitting smoking, this could cut down on new cases. Organisations such as the Alzheimer’s Society strongly support gene advice sessions and early action plans.

These efforts aim to ease the massive global burden, where dementia cost economies $1.3 trillion in 2019, mostly from care needs, as reported by the World Health Organization.

From a research view, how much dementia is passed down varies by type. Alzheimer's disease shows strong family ties: late onset types have 60 - 80% inheritance, while early onset ones from specific gene changes are nearly 100% inheritable.

Frontotemporal dementia is highly passed down in families, with about 30 - 40% of cases linked to family history.

Lewy body dementia has moderate inheritance, around 60% based on recent estimates.

Vascular dementia, however, is mostly driven by blood vessel issues like high blood pressure or strokes, rather than direct gene factors, though some genes play a role in risks.

Overall, 15 - 20% of dementia cases have a family connection, but only 1 - 2% come from gene changes that always lead to the disease.

This means most risks aren't set in stone. Factors outside genes, such as daily habits, heart health, and living conditions, can greatly influence outcomes. For instance, staying active and managing blood pressure might lower chances even if there's a family history. This opens doors for prevention strategies, like community programs promoting healthy living.

Gene testing is useful for rare family-linked cases but should always include expert advice to handle results well.

As science moves forward, blending gene discoveries with simple lifestyle tips will be crucial. This approach can lighten dementia's impact on society, helping people take control and reduce risks no matter their background. In the end, hope lies in combined efforts: more research funding, better education, and personal actions. By focusing on both genes and changeable factors, we can aim for fewer cases and better support for those affected, building a healthier future for everyone.